Skip to main content

Day: March 6, 2026

AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update

Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression remains on track for Q2 2026 following successful End‑of‑Phase 2 meeting with the U.S. Food and Drug Administration On-track for VLS-01 Phase 2 Elumina trial topline data readout anticipated in H2 2026 Exploratory Phase 2a trial of EMP-01 in Social Anxiety Disorder met its primary safety and tolerability objective and demonstrated clinically meaningful improvements across key efficacy measures Cash runway through the planned early-2029 topline readouts from both Phase 3 pivotal studies Virtual Investor Day scheduled for March 6, 2026NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) — AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or the “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting,...

Continue reading

Strategic Investor Agrees to $80 Million Investment in the Company at $2.00 Per Share, Preliminary Participation in Management, Followed by Subsequent Crypto Contribution

HANGZHOU, China, March 06, 2026 (GLOBE NEWSWIRE) — Jiuzi Holdings, Inc. (Nasdaq: JZXN, the “Company” or “Jiuzi”), today announced that it has reached an agreement and executed an investment agreement with a strategic investment institution possessing globally leading influence in the fields of crypto asset investment and Crypto treasury management. Pursuant to the agreement, the strategic investor will initially subscribe for 40 million ordinary shares of the Company at a price of $2.00 per share, representing a total investment amount of $80 million, to be funded in cash. This initial investment was completed and closed today, whereby the strategic investor has preliminarily commenced participation in the Company’s management, and both parties have reached a consensus on the plan to advance the subsequent...

Continue reading

MarketWise Reports Net Revenue of $83.4 Million and Net Income of $14.0 Million for Fourth Quarter 2025; Q4 Billings Increase 42% YoY; Beats FY 2025 Guidance for Billings and CFFO; Raises FY 2026 Guidance; Increases Regular Dividend by 25%, FY 2026 Dividend Target of $1.80 per Class A Share; Board Resumes $50M Share Buyback Program

BALTIMORE, March 06, 2026 (GLOBE NEWSWIRE) — MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors, today reported financial results for fourth quarter 2025.(1) Fourth Quarter 2025 Highlights(1)Total net revenue was $83.4 million in the fourth quarter 2025 (1)Total Billings were $78.9 million in fourth quarter 2025, a year-over-year increase of 42% Net income was $14.0 million in fourth quarter 2025 Cash from Operating Activities for fourth quarter 2025 improved $18.2 million compared to fourth quarter 2024. On a year to date basis, CFFO improved by $68.1 million compared to the year ended December 31, 2024. Cash and cash equivalents were $70.1 million...

Continue reading

SCHMID Group N.V. announces closing of the second tranche of its USD 30 million convertible notes financing

FREUDENSTADT, Germany, March 06, 2026 (GLOBE NEWSWIRE) — SCHMID Group N.V. (NASDAQ: SHMD) (the “Company”), a global leader in providing solutions to the high-tech electronics, photovoltaics, glass, and energy systems industries, announced today that it has issued the second $15.0 million tranche of its previously announced $30.0 million convertible notes financing under the investment agreement dated January 18, 2026 with an institutional investor (the “Investor“). The Company has issued and sold senior convertible notes in an aggregate principal amount of $30.0 million convertible into ordinary shares of the Company (the “Notes”) together with the issuance of warrants to purchase ordinary shares of the Company (the “Warrants”) in a private placement to the Investor (the Notes and Warrants together, the “Investment...

Continue reading

Form 8.3 – [IDOX PLC – 05 03 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

UP Fintech Holding Limited to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

SINGAPORE, March 06, 2026 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (“UP Fintech” or the “Company”) (NASDAQ: TIGR), a leading online brokerage firm focusing on global investors, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025, before the U.S. market opens on March 19, 2026. UP Fintech’s management will hold an earnings conference call at 8:00 AM on March 19, 2026, U.S. Eastern Time (8:00 PM on March 19, 2026, Singapore/Hong Kong Time). Conference Call Information: All participants wishing to attend the call must preregister online before they may receive the dial-in numbers. Preregistration may require a few minutes to complete. Preregistration Information: Please note that all participants will need to pre-register for the conference call, using the link:  https://register-conf.media-server.com/register/BI64386a93537e41cca665f4023e1048f3 It...

Continue reading

ROBERTET INVESTS IN AETHERA BIOTECH, A EUROPEAN PIONEER IN ACTIVE COSMETIC INGREDIENTS

ROBERTET INVESTS IN AETHERA BIOTECH,A EUROPEAN PIONEER IN ACTIVE COSMETIC INGREDIENTSEntering plant-based biotechnologies to advance Robertet’s “Augmented Naturality” strategy Strengthening Robertet’s position in cosmetic active ingredients Boosting long-term growth through a unique range of cosmetic ingredients Aethera will benefit from Robertet’s global networks of clients and commercial capabilitiesGrasse, March 5th, 2026 – Robertet, a world leader in natural raw materials for fragrances, flavors, and active ingredients announces the expansion of its partnership with Aethera Biotech through a strategic investment. This joint venture creates synergies between two family-owned groups sharing common values and a long-term vision. It combines Aethera Biotech’s advanced platform, proprietary intellectual property, production capabilities...

Continue reading

Resolution of the Extraordinary General Meeting of Shareholders of AB Akola Group

The Extraordinary General Meeting (hereinafter – the Meeting) of shareholders of AB Akola Group (hereinafter – the Company) was held on 6 March 2026. On the Accounting day of the Meeting (27/2/2026) the total number of the Company’s shares is 167,170,481, and the number of shares granting voting rights is 166,605,474. The own shares in the amount of 565,007 acquired by the Company do not grant voting rights. The decisions of the Meeting were adopted on the basis of 14 duly completed general voting ballots submitted prior to the Meeting, representing 134,875,460 share votes, which constitute 80.95 percent of all votes. The quorum existed. Decisions of the Meeting:Election of the assurance service provider for consolidated sustainability report of AB Akola Group.1.1.    Elect UAB ROSK Consulting, code 302692397, as the assurance service...

Continue reading

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of February 28, 2026

Press ReleaseVELIZY-VILLACOUBLAY, France — March 6, 2026                 Declaration of the number of outstanding shares and voting rights as of February 28, 2026 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of February 28, 2026, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,341,855,657 Number of voting rights*: 2,013,481,153 *The total number of voting rights is calculated on the basis of the total number of outstanding shares, even if the voting rights attached thereto are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers relating to the method for calculating the percentages of holdings in shares...

Continue reading

Full Year 2025 Results: Atos Group has Delivered on its Commitments to Restore its Foundations. Growth Chapter Ready to be Opened.

Press Release Full Year 2025 Results:Atos Group has Delivered on its Commitments to Restore its Foundations Growth Chapter Ready to be OpenedFY 2025 financial and extra financial targets met or exceeded:Revenue at €8,001 million, reflecting a clear improvement in the organic growth trajectory in Q4 Operating margin at €351 million, representing 4.4% of revenue, doubling year-on-year Net change in cash1 limited to €-326 million despite faster than expected execution of the restructuring program Greenhouse gas emissions reduced by 58% compared with the 2019 baseline.Execution of Genesis strategic and transformation plan ahead of schedule, with 88%2 of the three-year savings target completed in less than one year Strengthened commercial traction, with early signs of renewed client confidence Scaling artificial intelligence (AI) from...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.